Abstract:Background: Cluster of differentiation 36 (CD36) is a transmembrane glycoprotein involved in many biological processes, such as platelet biology, angiogenesis and in the aetiopathology of atherosclerosis and cardiovascular diseases. Toll-like receptors (TLRs) are one of the most important receptors of the innate immune system. Their main function is the recognition of conserved structure of microorganisms. This recognition triggers signaling pathways that activate transcription of cytokines and co-stimulatory molecules which participate in the generation of an immune response against microbes. In particular, TLR2 has been shown to recognize a broad range of ligands. Recently, we showed that CD36 serves as a co-receptor for TLR2 and enhances recognition of specific diacylglycerides derived from bacteria.Methodology/Principal Findings: Here, we investigate the mechanism by which CD36 contributes to ligand recognition and activation of TLR2 signaling pathway. We show that the ectodomain of murine CD36 (mCD36ED) directly interacts with negatively charged diacylglycerol ligands, which explains the specificity and selectivity of CD36 as a TLR2 co-receptor. We also show that mCD36ED amplifies the pro-inflammatory response to lipoteichoic acid in macrophages of wild-type mice and restores the pro-inflammatory response of macrophages from mice deficient in CD36 (oblivious), but not from mice deficient in cluster of differentiation 14 (CD14) (heedless).Conclusion/Significance: These data indicate that the CD36 ectodomain is the only relevant domain for activation of TLR2 signaling pathway and that CD36 and CD14 have a non-redundant role for loading ligands onto TLR2 in the plasma-membrane. The pro-inflammatory role of soluble CD36 can be relevant in the activation of the immune response against pathogens, as well as in the progression of chronic diseases. Therefore, an increased level of soluble forms of CD36, which has been reported to be increased in type II diabetic patients, could accelerate atherosclerosis by increasing the pro-inflammatory response to diacylglycerol ligands.

CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

CD36 and Its Role in Regulating the Tumor Microenvironment

CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

CD36 Tango in Cancer: Signaling Pathways and Functions

The function of CD36 in Mycobacterium tuberculosis infection

The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake

CD36 and Atherosclerosis

Soluble Cd36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands And Acts As A Co-Receptor For Tlr2

Slowly getting a clue on CD95 ligand biology.

CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting

CD36 Senses Dietary Lipids and Regulates Lipids Homeostasis in the Intestine

CD 36: Focus on Epigenetic and Post-Transcriptional Regulation

Ligand-dependent CD36 Functions in Cancer Progression, Metastasis, Immune Response, and Drug Resistance

CD36 in Atherosclerosis: the Role of a Class B Macrophage Scavenger Receptor

Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression

CD36 is a sensor of diacylglycerides

CD36 Protein is Involved in Store-Operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2.

Cd36 Level And Trafficking Are Determinants Of Lipolysis In Adipocytes

Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced Obesity

The Past and Present Lives of the Intraocular Transmembrane Protein CD36

Induction of CD36 Expression by Oxidized LDL and IL-4 by a Common Signaling Pathway Dependent on Protein Kinase C and PPAR-γ